The effects of atosiban on abnormal fetal heart rate patterns
dc.contributor.author | Tshivhula F. | |
dc.contributor.author | Grove D. | |
dc.contributor.author | Odendaal H.J. | |
dc.date.accessioned | 2011-05-15T16:16:21Z | |
dc.date.available | 2011-05-15T16:16:21Z | |
dc.date.issued | 2007 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Letter | |
dc.identifier.citation | European Journal of Obstetrics Gynecology and Reproductive Biology | |
dc.identifier.citation | 133 | |
dc.identifier.citation | 2 | |
dc.identifier.issn | 03012115 | |
dc.identifier.other | 10.1016/j.ejogrb.2006.07.019 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13742 | |
dc.subject | atosiban | |
dc.subject | adult | |
dc.subject | bradycardia | |
dc.subject | cardiotocography | |
dc.subject | cesarean section | |
dc.subject | drug effect | |
dc.subject | drug efficacy | |
dc.subject | face mask | |
dc.subject | female | |
dc.subject | fetus | |
dc.subject | fetus heart rate | |
dc.subject | heart arrhythmia | |
dc.subject | heart rate variability | |
dc.subject | human | |
dc.subject | letter | |
dc.subject | major clinical study | |
dc.subject | oxygen breathing | |
dc.subject | priority journal | |
dc.subject | single drug dose | |
dc.subject | solutio placentae | |
dc.subject | treatment indication | |
dc.subject | uterus contraction | |
dc.subject | vaginal delivery | |
dc.subject | Anthelmintics | |
dc.subject | Bradycardia | |
dc.subject | Cesarean Section | |
dc.subject | Female | |
dc.subject | Fetal Diseases | |
dc.subject | Heart Rate, Fetal | |
dc.subject | Humans | |
dc.subject | Pregnancy | |
dc.subject | Prospective Studies | |
dc.subject | Vasotocin | |
dc.title | The effects of atosiban on abnormal fetal heart rate patterns | |
dc.type | Letter |